Skip to main content
. 2017 May 3;7:1387. doi: 10.1038/s41598-017-01428-6

Figure 3.

Figure 3

In smokers under placebo medication, tDCS- and PAS-induced plasticity is abolished. Furthermore, PAS also induced no excitability alterations under 0.3 mg varenicline. High dose varenicline restituted both tDCS and PAS-induced after-effects, while 0.3 mg varenicline only restored tDCS-induced plasticity. Each column represents the mean of baseline-normalized MEP ± S.E.M. amplitudes until 30 minutes after stimulation; Asterisks indicate significant differences between drug and placebo conditions (Student’s t-test, two tailed, paired samples, p < 0.05).